Black Rock Inc. Alkermes Plc. Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Alkermes Plc. stock. As of the latest transaction made, Black Rock Inc. holds 29,107,548 shares of ALKS stock, worth $845 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
29,107,548
Previous 29,168,481
0.21%
Holding current value
$845 Million
Previous $790 Million
11.16%
% of portfolio
0.02%
Previous 0.02%
Shares
13 transactions
Others Institutions Holding ALKS
# of Institutions
401Shares Held
176MCall Options Held
901KPut Options Held
400K-
Vanguard Group Inc Valley Forge, PA18.2MShares$528 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD10.2MShares$297 Million0.03% of portfolio
-
State Street Corp Boston, MA8.54MShares$248 Million0.01% of portfolio
-
Baker Bros. Advisors LP New York, NY8.09MShares$235 Million1.98% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.29MShares$183 Million0.27% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $4.77B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...